JP2005504809A5 - - Google Patents

Download PDF

Info

Publication number
JP2005504809A5
JP2005504809A5 JP2003530703A JP2003530703A JP2005504809A5 JP 2005504809 A5 JP2005504809 A5 JP 2005504809A5 JP 2003530703 A JP2003530703 A JP 2003530703A JP 2003530703 A JP2003530703 A JP 2003530703A JP 2005504809 A5 JP2005504809 A5 JP 2005504809A5
Authority
JP
Japan
Prior art keywords
pyrimidin
tetrahydro
pyrimido
ethyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003530703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504809A (ja
JP4570361B2 (ja
Filing date
Publication date
Priority claimed from EP01402431A external-priority patent/EP1295884A1/en
Priority claimed from EP02290488A external-priority patent/EP1340760A1/en
Application filed filed Critical
Priority claimed from PCT/EP2002/011127 external-priority patent/WO2003027115A1/en
Publication of JP2005504809A publication Critical patent/JP2005504809A/ja
Publication of JP2005504809A5 publication Critical patent/JP2005504809A5/ja
Application granted granted Critical
Publication of JP4570361B2 publication Critical patent/JP4570361B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003530703A 2001-09-21 2002-09-19 置換した2−ピリミジニル−6,7,8,9−テトラヒドロピリミド[1,2−a]ピリミジン−4−オンおよび7−ピリミジニル−2,3−ジヒドロイミダゾ[1,2−a]ピリミジン−5(1H)オン誘導体 Expired - Fee Related JP4570361B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01402431A EP1295884A1 (en) 2001-09-21 2001-09-21 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 7-Pyrimidinyl-2,3-Dihydroimidazo[1,2-a]Pyrimidin-5(1H)one derivatives
EP02290488A EP1340760A1 (en) 2002-02-28 2002-02-28 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives
PCT/EP2002/011127 WO2003027115A1 (en) 2001-09-21 2002-09-19 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010097989A Division JP2010189422A (ja) 2001-09-21 2010-04-21 2−ピリミジニル−6,7,8,9−テトラヒドロピリミド[1,2−a]ピリミジン−4−オンおよび7−ピリミジニル−2,3−ジヒドロイミダゾ[1,2−a]ピリミジン−5(1H)オン誘導体を含む医薬組成物

Publications (3)

Publication Number Publication Date
JP2005504809A JP2005504809A (ja) 2005-02-17
JP2005504809A5 true JP2005504809A5 (https=) 2006-01-05
JP4570361B2 JP4570361B2 (ja) 2010-10-27

Family

ID=26077255

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003530703A Expired - Fee Related JP4570361B2 (ja) 2001-09-21 2002-09-19 置換した2−ピリミジニル−6,7,8,9−テトラヒドロピリミド[1,2−a]ピリミジン−4−オンおよび7−ピリミジニル−2,3−ジヒドロイミダゾ[1,2−a]ピリミジン−5(1H)オン誘導体
JP2010097989A Pending JP2010189422A (ja) 2001-09-21 2010-04-21 2−ピリミジニル−6,7,8,9−テトラヒドロピリミド[1,2−a]ピリミジン−4−オンおよび7−ピリミジニル−2,3−ジヒドロイミダゾ[1,2−a]ピリミジン−5(1H)オン誘導体を含む医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010097989A Pending JP2010189422A (ja) 2001-09-21 2010-04-21 2−ピリミジニル−6,7,8,9−テトラヒドロピリミド[1,2−a]ピリミジン−4−オンおよび7−ピリミジニル−2,3−ジヒドロイミダゾ[1,2−a]ピリミジン−5(1H)オン誘導体を含む医薬組成物

Country Status (23)

Country Link
US (2) US7388005B2 (https=)
EP (1) EP1430056B1 (https=)
JP (2) JP4570361B2 (https=)
KR (1) KR100868840B1 (https=)
CN (1) CN1247586C (https=)
AR (1) AR036599A1 (https=)
AT (1) ATE307815T1 (https=)
AU (1) AU2002342798C1 (https=)
BR (1) BR0212904A (https=)
CA (1) CA2457952C (https=)
CY (1) CY1105553T1 (https=)
DE (1) DE60206946T2 (https=)
DK (1) DK1430056T3 (https=)
EA (2) EA007165B1 (https=)
ES (1) ES2250721T3 (https=)
HU (1) HUP0500332A3 (https=)
IL (2) IL160397A0 (https=)
MX (1) MXPA04002632A (https=)
NO (1) NO329566B1 (https=)
NZ (1) NZ531244A (https=)
PL (1) PL370535A1 (https=)
SI (1) SI1430056T1 (https=)
WO (1) WO2003027115A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454909B1 (en) * 2003-03-07 2008-08-20 Sanofi Aventis 8'-pyridinyl-dihydrospiro- (cycloalkyl) -pyrimido (1,2-a) pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro (cycloalkyl) -pyrimido (1,2-a) pyrimidin-6-one derivatives and their use against neurodegenerative diseases
EP1557417B1 (en) * 2003-12-19 2007-03-07 Sanofi-Aventis Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a] pyrimidin-6-one derivatives
WO2005070932A2 (en) 2004-01-22 2005-08-04 Amgen Inc. Substituted heterocyclic compounds and methods of use
AU2006259675A1 (en) * 2005-06-14 2006-12-28 Schering Corporation Aspartyl protease inhibitors
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP1939187A1 (en) * 2006-12-20 2008-07-02 Sanofi-Aventis Substituted heteroaryl pyridopyrimidone derivatives
EP1992621A1 (en) * 2007-05-16 2008-11-19 Sanofi-Aventis Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
EP1992620A1 (en) * 2007-05-16 2008-11-19 Sanofi-Aventis Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases
EP1992625A1 (en) 2007-05-16 2008-11-19 Sanofi-Aventis Arylamide pyrimidone compounds
EP1992624A1 (en) * 2007-05-16 2008-11-19 Sanofi-Aventis Heteroarylamide pyrimidone compounds
EP2090579A1 (en) * 2008-01-29 2009-08-19 Sanofi-Aventis Substituted heteroarylamide diazepinopyrimidone derivatives
EP2085400A1 (en) * 2008-01-29 2009-08-05 Sanofi-Aventis Substituted heteroarylamide oxazepinopyrimidone derivatives
EP2090578A1 (en) * 2008-01-29 2009-08-19 Sanofi-Aventis Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta
EP2085399A1 (en) * 2008-01-29 2009-08-05 Sanofi-Aventis substituted arylamide oxazepinopyrimidone derivatives
EP2138493A1 (en) 2008-06-26 2009-12-30 Sanofi-Aventis Substituted pyrimidone derivatives
EP2138498A1 (en) 2008-06-26 2009-12-30 sanofi-aventis Substituted tricyclic derivatives against neurodegenerative diseases
EP2138494A1 (en) * 2008-06-26 2009-12-30 Sanofi-Aventis Substituted alkyl pyrimidin-4-one derivatives
EP2138488A1 (en) 2008-06-26 2009-12-30 sanofi-aventis 4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases
EP2138495A1 (en) 2008-06-26 2009-12-30 sanofi-aventis Substituted pyrimido[2,1-a]isoquinolin-4-one derivatives
EP2138492A1 (en) 2008-06-26 2009-12-30 Sanofi-Aventis Substituted pyrimidin-4-one derivatives
EP2138485A1 (en) 2008-06-26 2009-12-30 sanofi-aventis Substituted N-Oxide pyrazine derivatives
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US8421890B2 (en) 2010-01-15 2013-04-16 Picofield Technologies, Inc. Electronic imager using an impedance sensor grid array and method of making
CA2945263A1 (en) 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
JP7403351B2 (ja) 2020-02-27 2023-12-22 三菱重工業株式会社 通信ポイント決定装置、通信ポイント決定方法およびプログラム、並びに点検システム

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865836A (en) * 1972-12-08 1975-02-11 Janssen Pharmaceutica Nv Bicyclic imidazoles
SU600143A1 (ru) * 1976-12-06 1978-03-30 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвийской Сср Способ получени гетероциклических систем, содержащих бормзамещенный имидазол
JPS63216886A (ja) * 1987-03-05 1988-09-09 Sumitomo Chem Co Ltd ピリミドピリミジン誘導体およびその製造法
JP2862958B2 (ja) * 1990-06-09 1999-03-03 三協化学株式会社 感熱転写記録用色素
WO1998016528A1 (en) * 1996-10-11 1998-04-23 Chiron Corporation Purine inhibitors of glycogen synthase kinase 3 (gsk3)
EP0948496A2 (en) 1996-12-05 1999-10-13 Amgen inc. Substituted pyrimidinone and pyridone compounds and methods of use
EA200000840A1 (ru) * 1998-02-17 2001-02-26 Туларик, Инк. Антивирусные производные пиримидина
CN100335479C (zh) * 1999-12-17 2007-09-05 希龙公司 糖元合成酶激酶3的双环抑制剂
FR2804959B1 (fr) 2000-02-15 2006-04-28 Centre Nat Rech Scient Utilisation de derives de paullones pour la fabrication de medicaments

Similar Documents

Publication Publication Date Title
JP2005504809A5 (https=)
CA2457952A1 (en) Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders
JP2024532735A (ja) 複素環式化合物及び使用方法
AU2023222076A1 (en) Quinazoline compounds and use thereof as inhibtors of mutant kras proteins
CA2407593A1 (en) Fused heteroaryl derivatives
RU2328497C2 (ru) Конденсированные производные пиримидина и лекарственное средство, обладающее активностью в отношении crf
DK2168966T3 (en) BICYCLOANILIN DERIVATIVES
CA2457965A1 (en) Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
RU2000110738A (ru) Бициклические ингибиторы киназ
RU2007126570A (ru) Аминоимидазолоны, применяемые для ингибирования бета-секретазы
RU2001118284A (ru) Новые соединения триазоло (4,5-D) пиримидина
CA2351709A1 (en) Novel triazolo(4,5-d)pyrimidine compounds
RU99105137A (ru) Пиразолопиримидины и пиразолотриазины
JP2021525783A5 (https=)
KR20190080897A (ko) 치환된 피리디논 함유 트리시클릭 화합물, 및 그의 사용 방법
NZ521633A (en) Use of an adenosine A2 or A2b recpetor antagonist for promoting bowel movement
Dymock et al. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010–2012
MXPA05000814A (es) Inhibidores de quinasas.
WO2004074270B1 (en) Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
JP2005519086A5 (https=)
CA2316662A1 (en) Use of crf antagonists and related compositions
RU2009127842A (ru) ПРОИЗВОДНЫЕ 5,6,7,8-ТЕТРАГИДРОИМИДАЗО[1.5-а]ПИРАЗИНА
RU2014115478A (ru) Новые гетероциклические производные и их применения
JP2005519087A5 (https=)
CA2518299A1 (en) 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives